Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes (Q37331262)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes |
scientific article |
Statements
1 reference
Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes (English)
1 reference
Ele Ferrannini
1 reference
Andreas Berk
1 reference
Stefan Hantel
1 reference
Sabine Pinnetti
1 reference
Thomas Hach
1 reference
Hans J Woerle
1 reference
Uli C Broedl
1 reference
Identifiers
1 reference